机译:新生儿和儿童药物治疗的发展
Division of Pediatric and Maternal Health CDER US Food and Drug Administration;
Obstetric and Pediatric Pharmacology and Therapeutics Branch Eunice Kennedy Shriver National;
Sanofi Pharmaceuticals;
Division of Pediatric and Maternal Health CDER US Food and Drug Administration;
Division of Pediatric and Maternal Health CDER US Food and Drug Administration;
Merck &
Co. Inc;
Division of Pediatric and Maternal Health CDER US Food and Drug Administration;
Pediatric; Neonatal; Research; Extrapolation; Dosing; Regulations;
机译:新生儿和儿童药物治疗的发展
机译:新生儿和儿童药物性肝损伤的发展方法。
机译:在开发针对儿童特异性免疫疗法的过敏原产品时,学术界,行业和药物监管机构之间需要紧密合作。
机译:新生儿和儿童有机磷农药暴露的神经发育和神经障碍效应
机译:七岁儿童的产前微量营养素补充,产妇营养状况,新生儿大小和代谢综合征的生物标志物:探讨尼泊尔农村地区健康和疾病的发展起源。
机译:新生儿和儿童药物治疗的发展
机译:新生儿和儿童药物疗法的发展